Carnosine inhibits growth of cells isolated from human glioblastoma multiforme

International Journal of Peptide Research and Therapeutics

Volumn 14, Issue 2, 2008, Pages 127-135

  Renner, Christof ^a   Seyffarth, Anne ^a   De Arriba, Susana Garcia ^a   Meixensberger, Jürgen ^a   Gebhardt, Rolf ^a   Gaunitz, Frank ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Carnosine; Cell based assays; Human glioblastoma; Proliferation

Indexed keywords

ADENOSINE TRIPHOSPHATE; BROXURIDINE; CARNOSINE; CASPASE; LACTATE DEHYDROGENASE; OXIDOREDUCTASE;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME RELEASE; GLIOBLASTOMA; HUMAN; HUMAN CELL; INCUBATION TIME; QUANTITATIVE ANALYSIS;

EID: 43549104039     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-007-9121-0     Document Type: Article

References (40)

1. Baran EJ (2000) Metal complexes of carnosine. Biochemistry (Mosc) 65:789-797
2. Bauer K (2005) Carnosine and homocarnosine, the forgotten, enigmatic peptides of the brain. Neurochem Res 30:1339-1345
3. Bauer K, Hallermayer K, Salnikow J, Kleinkauf H, Hamprecht B (1982) Biosynthesis of carnosine and related peptides by glial cells in primary culture. J Biol Chem 257:3593-3597
4. Boldyrev A, Song R, Lawrence D, Carpenter DO (1999) Carnosine protects against excitotoxic cell death independently of effects on reactive oxygen species. Neuroscience 94:571-577
5. Boldyrev AA (2000) Problems and perspectives in studying the biological role of carnosine. Biochemistry (Mosc) 65:751-756
6. Boldyrev AA, Severin SE (1990) The histidine-containing dipeptides, carnosine and anserine: distribution, properties and biological significance. Adv Enzyme Regul 30:175-194
7. Brandes AA (2003) State-of-the-art treatment of high-grade brain tumors. Semin Oncol 30:4-9
8. Chez MG, Buchanan CP, Aimonovitch MC, Becker M, Schaefer K, Black C, Komen J (2002) Double-blind, placebo-controlled study of l-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol 17:833-837
9. Crouch SP, Kozlowski R, Slater KJ, Fletcher J (1993) The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 160:81-88
10. Fontana M, Pinnen F, Lucente G, Pecci L (2002) Prevention of peroxynitrite-dependent damage by carnosine and related sulphonamido pseudodipeptides. Cell Mol Life Sci 59:546-551
11. Gallant S, Semyonova M, Yuneva M (2000) Carnosine as a potential anti-senescence drug. Biochemistry (Mosc) 65:866-868
12. Gaunitz F, Heise K (2003) HTS compatible assay for antioxidative agents using primary cultured hepatocytes. Assay Drug Dev Technol 1:469-477
13. Guiotto A, Calderan A, Ruzza P, Borin G (2005) Carnosine and carnosine-related antioxidants: a review. Curr Med Chem 12:2293-2315
14. Gulewitsch W, Amiradzibi S (1900) Ueber das Carnosin, eine neue organische Base des Fleischextraktes. Ber Deut Chem Ges 33:1902-1903
15. Hipkiss AR (1998) Carnosine, a protective, anti-ageing peptide? Int J Biochem Cell Biol 30:863-868
16. Hipkiss AR (2007) Could carnosine or related structures suppress Alzheimer's disease? J Alzheimers Dis 11:229-240
17. Hipkiss AR, Chana H (1998) Carnosine protects proteins against methylglyoxal-mediated modifications. Biochem Biophys Res Commun 248:28-32
18. Hipkiss AR, Michaelis J, Syrris P (1995) Non-enzymatic glycosylation of the dipeptide l-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett 371:81-85
19. Hipkiss AR, Preston JE, Himsworth DT, Worthington VC, Keown M, Michaelis J, Lawrence J, Mateen A, Allende L, Eagles PA, Abbott NJ (1998a) Pluripotent protective effects of carnosine, a naturally occurring dipeptide. Ann N Y Acad Sci 854:37-53
20. Hipkiss AR, Preston JE, Himswoth DT, Worthington VC, Abbot NJ (1997) Protective effects of carnosine against malondialdehyde-induced toxicity towards cultured rat brain endothelial cells. Neurosci Lett 238:135-138
21. Hipkiss AR, Worthington VC, Himsworth DT, Herwig W (1998b) Protective effects of carnosine against protein modification mediated by malondialdehyde and hypochlorite. Biochim Biophys Acta 1380:46-54
22. Holliday R, McFarland GA (1996) Inhibition of the growth of transformed and neoplastic cells by the dipeptide carnosine. Br J Cancer 73:966-971
23. Holliday R, McFarland GA (2000) A role for carnosine in cellular maintenance. Biochemistry (Mosc) 65:843-848
24. Jagannathan J, Prevedello DM, Dumont AS, Laws ER (2006) Cellular signaling molecules as therapeutic targets in glioblastoma multiforme. Neurosurg Focus 20:E8
25. Kalyankar GD, Meister A (1959) Enzymatic synthesis of carnosine and related beta-alanyl and gamma-aminobutyryl peptides. J Biol Chem 234:3210-3218
26. Kangas L, Gronroos M, Nieminen AL (1984) Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro. Med Biol 62:338-343
27. Kohen R, Yamamoto Y, Cundy KC, Ames BN (1988) Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proc Natl Acad Sci USA 85:3175-3179
28. Margolis FL (1980) Carnosine: an olfactory neuropeptide. In: Barker JL, Smith TG Jr (eds) The role of peptides in neuronal function. Marcel Decker, New York, pp 545-572
29. McFarland GA, Holliday R (1994) Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res 212:167-175
30. Nadi NS, Hirsch JD, Margolis FL (1980) Laminar distribution of putative neurotransmitter amino acids and ligand binding sites in the dog olfactory bulb. J Neurochem 34:138-146
31. Norden AD, Wen PY (2006) Glioma therapy in adults. Neurologist 12:279-292
32. Pisano JJ, Wilson JD, Cohen L, Braham D, Udenfried S (1961) Isolation of gamma-aminobutyrylhistidine (homocarnosine) from brain. J Biol Chem 236:499-502
33. Preston JE, Hipkiss AR, Himsworth DT, Romero IA, Abbott JN (1998) Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine. Neurosci Lett 242:105-108
34. Quinn PJ, Boldyrev AA, Formazuyk VE (1992) Carnosine: its properties, functions and potential therapeutic applications. Mol Aspects Med 13:379-444
35. Reddy VP, Garrett MR, Perry G, Smith MA (2005) Carnosine: a versatile antioxidant and antiglycating agent. Sci Aging Knowledge Environ 18:e12
36. Schulz M, Hamprecht B, Kleinkauf H, Bauer K (1987) Peptide uptake by astroglia-rich brain cultures. J Neurochem 49:748-755
37. Scriver CR, Perry TL, Nutzenadel W (1983), In: Stanbury JB et al. (eds) The metabolic basis of inherited disease, 5th edn. McGraw-Hill, New York, pp 570-585
38. Smith EC (1938) The buffering of muscle in rigor; protein, phosphate and carnosine. J Physiol 92:336-343
39. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
40. Teuscher NS, Novotny A, Keep RF, Smith DE (2000) Functional evidence for presence of PEPT2 in rat choroid plexus: studies with glycylsarcosine. J Pharmacol Exp Ther 294:494-499